tiprankstipranks
Advertisement
Advertisement

CHRO Stock Latest News

Genentech granted priority review for Gazyva sBLA by FDA
The FlyGenentech granted priority review for Gazyva sBLA by FDA
4d ago
CHRO
Nurix Therapeutics price target raised to $34 from $32 at Truist
PremiumThe Fly
Nurix Therapeutics price target raised to $34 from $32 at Truist
9d ago
CHRO
NRIX
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
PremiumThe Fly
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
9d ago
CHRO
NRIX
Roche receives CE Mark for blood test to identify tuberculosis infection
PremiumThe Fly
Roche receives CE Mark for blood test to identify tuberculosis infection
10d ago
CHRO
Roche downgraded to Hold from Buy at HSBC
PremiumThe Fly
Roche downgraded to Hold from Buy at HSBC
13d ago
CHRO
Genentech announces Krascendo 1 study met primary, key secondary endpoint
PremiumThe FlyGenentech announces Krascendo 1 study met primary, key secondary endpoint
17d ago
CHRO
AI Daily: Amazon’s AWS commits $1B toward new unit
Premium
The Fly
AI Daily: Amazon’s AWS commits $1B toward new unit
19d ago
AZN
BMY
Anthropic takes aim at pharma industry with Claude Science, STAT reports
Premium
The Fly
Anthropic takes aim at pharma industry with Claude Science, STAT reports
19d ago
AZN
BMY
Genentech announces priority review for Enspryng
PremiumThe Fly
Genentech announces priority review for Enspryng
19d ago
CHRO
Roche announces launch of AXELIOS 1, a next-gen sequencing platform
PremiumThe Fly
Roche announces launch of AXELIOS 1, a next-gen sequencing platform
20d ago
CHRO
Sanofi investors likely to view new R&D head as a positive, says BofA
PremiumThe Fly
Sanofi investors likely to view new R&D head as a positive, says BofA
27d ago
SNY
CHRO
Nurix Therapeutics price target raised to $33 from $26 at Baird
PremiumThe Fly
Nurix Therapeutics price target raised to $33 from $26 at Baird
1M ago
CHRO
NRIX
Genentech says FDA accepts sBLA for for Lunsumio VELO
PremiumThe FlyGenentech says FDA accepts sBLA for for Lunsumio VELO
1M ago
CHRO
FDA approves generic of Genentech’s Xofluza tablets
Premium
The Fly
FDA approves generic of Genentech’s Xofluza tablets
1M ago
CHRO
CMS proposes to lock in lower prices in Medicare drug price negotiation program
Premium
The Fly
CMS proposes to lock in lower prices in Medicare drug price negotiation program
1M ago
AZN
BMY
Roche reports FDA approval for prostate cancer companion diagnostic
PremiumThe Fly
Roche reports FDA approval for prostate cancer companion diagnostic
1M ago
AZN
CHRO
OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit
PremiumThe Fly
OraSure announces FDA clearance of Colli-Pee Dx Urine Collection Kit
1M ago
CHRO
OSUR
Genentech granted priority review for Tecentriq Hybreza combination
PremiumThe Fly
Genentech granted priority review for Tecentriq Hybreza combination
1M ago
CHRO
Roche announces EU IVDR approval of several Ventana label expansions
PremiumThe Fly
Roche announces EU IVDR approval of several Ventana label expansions
1M ago
CHRO
Nurix Therapeutics price target raised to $32 from $30 at Truist
PremiumThe FlyNurix Therapeutics price target raised to $32 from $30 at Truist
1M ago
CHRO
NRIX
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
Premium
The Fly
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
1M ago
CHRO
NRIX
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
Premium
The Fly
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
1M ago
CHRO
NRIX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >